LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Articles
Gtx Inc.
Headquarters:
Memphis, TN, United States
Website:
N/A
Year Founded:
1997
Status:
Reverse-merged
BioCentury
|
Dec 8, 2020
Product Development
ADC and ROR1 momentum grows with ASH data behind Merck, VelosBio deal
ASH data presented by VelosBio — which drove the latest in a string of high wattage ADC deals — is building confidence in a target valued for its potential in both solid and
Read More
BioCentury
|
Mar 14, 2019
Company News
GTx and Oncternal merging
Read More
BioCentury
|
Sep 28, 2018
Clinical News
GTx's enobosarm fails Phase II for stress urinary incontinence
Read More
BioCentury
|
Sep 21, 2018
Clinical News
GTx shares crater after incontinence readout
Read More
BioCentury
|
Aug 10, 2018
Finance
Missing the obvious
Aisling’s Seltzer on why women’s health is underserved and ripe for investment
Read More
BioCentury
|
Mar 9, 2018
Clinical News
GTx reports additional Phase II stress urinary incontinence data for enobosarm
Read More
BioCentury
|
Mar 5, 2018
Clinical News
GTx rises on stress urinary incontinence data
Read More
BioCentury
|
Oct 31, 2017
Distillery Therapeutics
Cancer
Read More
BioCentury
|
Sep 29, 2017
Financial News
Public financing roundup: Kadmon, TherapeuticsMD, GTx, Newron
Read More
BioCentury
|
Sep 27, 2017
Financial News
Public financing roundup: Kadmon, TherapeuticsMD, GTx, Newron
Read More
Items per page:
10
1 - 10 of 187
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help